Enzyme-linked Immunosorbent Assay for Quantitation of Human Antibodies to Pneumococcal Polysaccharides

Overview

Journal Clin Diagn Lab Immunol

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 2003 Jul 11

PMID 12853378

Citations 126

Authors

Catherine M Wernette

Carl E Frasch

Dace Madore

George Carlone

David Goldblatt

Brian Plikaytis

William Benjamin

Sally A Quataert

Steve Hildreth

Daniel J Sikkema

Helena Kayhty

Ingileif Jonsdottir

Moon H Nahm

Affiliations

Soon will be listed here.

Citing Articles

Establishing a new human pneumococcal standard reference serum, MPRSS-01.

Antonello J, Murphy R, Abeygunawardana C, Malinverni J, Gowrisankar R, Green T mSphere. 2025; 10(1):e0040424.

PMID: 39772874 PMC: 11774022. DOI: 10.1128/msphere.00404-24.

Clinical features and immune memory of breakthrough infection in children after age-appropriate 13-valent pneumococcal conjugate vaccination in Taiwan.

Chen C, Hsu M, Ou-Yang M, Yin C, Li H, Su L Infection. 2024; .

PMID: 39499493 DOI: 10.1007/s15010-024-02426-3.

Implications of Cross-Reactivity and Cross-Protection for Pneumococcal Vaccine Development.

Feemster K, Hausdorff W, Banniettis N, Platt H, Velentgas P, Esteves-Jaramillo A Vaccines (Basel). 2024; 12(9).

PMID: 39340006 PMC: 11435891. DOI: 10.3390/vaccines12090974.

Development and validation of carbodiimide-activated ELISA plate for quantifying IgG levels against capsular polysaccharides.

Ramakrishnan S, Mavupadi A, Govindan V, Nagaraj G, Ravikumar K Bioanalysis. 2024; 16(13):641-650.

PMID: 39254501 PMC: 11389740. DOI: 10.1080/17576180.2024.2349453.

Current challenges and improvements in assessing the immunogenicity of bacterial vaccines.

Fantoni G, Boccadifuoco G, Verdirosa F, Molesti E, Manenti A, Montomoli E Front Microbiol. 2024; 15:1404637.

PMID: 39044946 PMC: 11263209. DOI: 10.3389/fmicb.2024.1404637.

References

Schiffman G, Douglas R, Bonner M, Robbins M, Austrian R . A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. I. Method for the radioimmunoassay of anticapsular antibodies and comparison with other techniques. J Immunol Methods. 1980; 33(2):133-44. DOI: 10.1016/s0022-1759(80)80004-4. View

Concepcion N, Frasch C . Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcal-polysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol. 2001; 8(2):266-72. PMC: 96047. DOI: 10.1128/CDLI.8.2.266-272.2001. View

Plikaytis B, Turner S, Gheesling L, Carlone G . Comparisons of standard curve-fitting methods to quantitate Neisseria meningitidis group A polysaccharide antibody levels by enzyme-linked immunosorbent assay. J Clin Microbiol. 1991; 29(7):1439-46. PMC: 270131. DOI: 10.1128/jcm.29.7.1439-1446.1991. View

Katz M, Landesman S, Schiffman G . A comparison of antibody concentration measured by mouse protection assay and radioimmunoassay in sera from patients at high risk of developing pneumococcal disease. Mol Immunol. 1984; 21(11):1061-5. DOI: 10.1016/0161-5890(84)90116-0. View

Johnson S, Rubin L, Romero-Steiner S, Dykes J, Pais L, Rizvi A . Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae. J Infect Dis. 1999; 180(1):133-40. DOI: 10.1086/314845. View

Redd S, Rutherford 3rd G, Sande M, Lifson A, Hadley W, Facklam R . The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis. 1990; 162(5):1012-7. DOI: 10.1093/infdis/162.5.1012. View

Sun Y, Hwang Y, Nahm M . Avidity, potency, and cross-reactivity of monoclonal antibodies to pneumococcal capsular polysaccharide serotype 6B. Infect Immun. 2000; 69(1):336-44. PMC: 97888. DOI: 10.1128/IAI.69.1.336-344.2001. View

Jakobsen H, Bjarnarson S, Del Giudice G, Moreau M, Siegrist C, Jonsdottir I . Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice. Infect Immun. 2002; 70(3):1443-52. PMC: 127807. DOI: 10.1128/IAI.70.3.1443-1452.2002. View

Nahm M, Siber G, Olander J . A modified Farr assay is more specific than ELISA for measuring antibodies to Streptococcus pneumoniae capsular polysaccharides. J Infect Dis. 1996; 173(1):113-8. DOI: 10.1093/infdis/173.1.113. View

10.

Plikaytis B, Goldblatt D, Frasch C, Blondeau C, Bybel M, Giebink G . An analytical model applied to a multicenter pneumococcal enzyme-linked immunosorbent assay study. J Clin Microbiol. 2000; 38(6):2043-50. PMC: 86724. DOI: 10.1128/JCM.38.6.2043-2050.2000. View

11.

Saeland E, Vidarsson G, Jonsdottir I . Pneumococcal pneumonia and bacteremia model in mice for the analysis of protective antibodies. Microb Pathog. 2000; 29(2):81-91. DOI: 10.1006/mpat.2000.0363. View

12.

Musher D, Chapman A, Goree A, Jonsson S, Briles D, Baughn R . Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis. 1986; 154(2):245-56. DOI: 10.1093/infdis/154.2.245. View

13.

Anttila M, Voutilainen M, Jantti V, Eskola J, Kayhty H . Contribution of serotype-specific IgG concentration, IgG subclasses and relative antibody avidity to opsonophagocytic activity against Streptococcus pneumoniae. Clin Exp Immunol. 1999; 118(3):402-7. PMC: 1905437. DOI: 10.1046/j.1365-2249.1999.01077.x. View

14.

Powers D, Anderson E, LOTTENBACH K, Mink C . Reactogenicity and immunogenicity of a protein-conjugated pneumococcal oligosaccharide vaccine in older adults. J Infect Dis. 1996; 173(4):1014-8. DOI: 10.1093/infdis/173.4.1014. View

15.

Koskela M . Serum antibodies to pneumococcal C polysaccharide in children: response to acute pneumococcal otitis media or to vaccination. Pediatr Infect Dis J. 1987; 6(6):519-26. DOI: 10.1097/00006454-198706000-00006. View

16.

Nahm M, Olander J, Magyarlaki M . Identification of cross-reactive antibodies with low opsonophagocytic activity for Streptococcus pneumoniae. J Infect Dis. 1997; 176(3):698-703. DOI: 10.1086/514093. View

17.

Matsuura E, Igarashi Y, Yasuda T, Triplett D, Koike T . Anticardiolipin antibodies recognize beta 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med. 1994; 179(2):457-62. PMC: 2191370. DOI: 10.1084/jem.179.2.457. View

18.

Robbins J, Austrian R, Lee C, Rastogi S, Schiffman G, HENRICHSEN J . Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis. 1983; 148(6):1136-59. DOI: 10.1093/infdis/148.6.1136. View

19.

Mbelle N, Huebner R, Wasas A, Kimura A, Chang I, Klugman K . Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis. 1999; 180(4):1171-6. DOI: 10.1086/315009. View

20.

Coughlin R, White A, Anderson C, Carlone G, Klein D, Treanor J . Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine. 1998; 16(18):1761-7. DOI: 10.1016/s0264-410x(98)00139-x. View